About
Solutions
Pipeline
Publications
News
Careers
Contact Us
en
Open main menu
News
Loading...
CN
Track Our News on
All
Press Release
Media Coverage
All
2023-10-11
2023-09-07
2023-09-01
2023-08-10
2023-07-29
2023-07-18
2023-06-12
2023-04-05
2023-01-17
2023-01-12
2022-12-23
2022-12-19
Previous
3 / 5
Next
Previous
3 / 5
Next
Bioinformatics | An Extensive Benchmark Study on Biomedical Text Generation and Mining with ChatGPT
MindRank Announces the Commencement of Phase IIa Clinical Study of MDR-001 in China
MindRank Features in Forbes Asia 100 to Watch 2023 List
MindRank Secures Funding from the Dynamic Resilience Program for its Pan-European Collaborative Project
ICML 2023 | Rethinking Explaining Graph Neural Networks via Non-parametric Subgraph Matching
MindRank Secures Over $20 Million in A+ Round Financing, Propelling Innovative Drug Pipeline and AI Platform Commercialization
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
Commun. Chem. (Nature) | Pharmacophoric-Constrained Heterogeneous Graph Transformer Model for Molecular Property Prediction
MindRank Made the List of 2022 China's Top 10 Most Potential ScienceAI Startups by Synced
MindRank was Nominated for the 2022 Venture50 List by Zero2IPO Group and Pedaily
News - MindRank
MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity
MindRank was Nominated "the TOP100 Most Innovative Medical Technology Products (Solutions) 2022" by VBDATA
